Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

(J. Scott Applewhite / AP)

Last week, Speaker Paul Ryan told reporters the House won't drop its lawsuit against the Trump administration — originally filed against the Obama administration — over Obamacare's insurer subsidies that lower out-of-pocket costs for low-income people. And on Monday, the administration said it'll keep paying the subsidies while the case is being litigated, per The Hill.

While this was new information, it didn't fully answer the question of what either party will do next. Both Congress and the administration still have major decisions to make, and the sooner they make them, the better for insurers. Here are the options, according to legal experts.

The House argument: The payments are being made illegally, as Congress never passed a law funding them. A district court judge has agreed with the House, but the Obama administration appealed the case before Trump was sworn in. In February, the case was delayed and is currently on hold, but the first check-in will be in May.

What now? Here are the options for both the House and the Trump administration going forward.

The administration:

  • Drop the appeal of the case, essentially accepting the district judge's ruling. The payments would then stop. It would also keep the district court precedent that Congress can sue the administration.It could also appeal only the decision that the House can legally sue the administration. But that wouldn't settle the issue of the payments.
  • Keep fighting the case, paying insurers the subsidies in the meantime.
  • The administration would then either wait for the court to make a decision, or for Congress to pass a law giving the money. Either would settle the issue.
  • The case could also be delayed indefinitely. This would keep the payments flowing to insurers, although it wouldn't give them any kind of concrete certainty.
  • Try to settle the case. But this could also get really awkward. Legally, both parties would likely have to take the case back to district court and then make the argument that they want to keep making the payments, even though almost everyone involved opposed them when Barack Obama was still president.

The House:

  • Wait for the lawsuit to be decided and do nothing in the meantime.
  • Pass a law giving insurers the money, most likely packaged with a short-term spending bill that must be passed by the end of April to keep the government running. The subsidy spending provision could be short-term, either through the end of 2017 or 2018 to give insurers short-term clarity. Or it could be permanent, giving insurers certainty that they'll receive the payments indefinitely.

Why this matters: Insurers have to pass along the subsidies to low-income people; that part of Obamacare isn't being questioned. Insurers say it's critical that they continue receiving the money, especially in light of challenges they're already having making a profit on exchanges.

Bottom line: They need guidance soon, as they have to make crucial 2018 decisions beginning in a few weeks. If the money isn't paid, or there's still uncertainty about the issue, insurers could exit the market in droves, premiums could skyrocket, or both.

Go deeper

Updated 46 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Health: Trump received COVID vaccine at White House in January — CDC director warns "now is not the time" to lift COVID restrictions.
  2. Education: More schools are reopening in the U.S.
  3. Vaccine: J&J CEO "absolutely" confident in vaccine distribution goals Most states aren't prioritizing prisons for COVID vaccines — Vaccine hesitancy is shrinking.
  4. Economy: Apple says all U.S. stores open for the first time since start of pandemic — What's really going on with the labor market.
  5. Sports: Poll weighs impact of athlete vaccination.
  6. World: Latin America turns to China and Russia for COVID-19 vaccines.
Dave Lawler, author of World
1 hour ago - World

Latin America turns to China and Russia for COVID-19 vaccines

Several countries in the Americas have received their first vaccine shipments over the past few weeks — not from the regional superpower or from Western pharmaceutical giants, but from China, Russia, and in some cases India.

Why it matters: North and South America have been battered by the pandemic and recorded several of the world’s highest death tolls. Few countries other than the U.S. have the capacity to manufacture vaccines at scale, and most lack the resources to buy their way to the front of the line for imports. That’s led to a scramble for whatever supply is available.

More schools are reopening in the U.S.

Students settle into a classroom in New York City. Photo: Michael Loccisano/Getty Images

More than 72% of K-12 students are now attending schools that offer in-person or hybrid models of learning.

The big picture: The U.S. is seeing an almost-universal return of schools that were in-person as of November, as well as a gradual return in parts of the country that had been virtual for almost a year.